462510 — Lameditech Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩101bn
- KR₩98bn
- KR₩3bn
Annual cashflow statement for Lameditech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | KAS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -1,867 | -4,430 | -8,305 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 295 | 1,337 | 4,916 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -252 | -529 | -667 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Other Liabilities | |||
| Net Change in Other Assets & Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -1,823 | -3,387 | -3,760 |
| Capital Expenditures | -198 | -314 | -156 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | -5.05 | -69.2 | -4,002 |
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -203 | -384 | -4,159 |
| Financing Cash Flow Items | 17.2 | 1,542 | -6.39 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 5,353 | 1,573 | 6,293 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 3,327 | -2,203 | -1,630 |